These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 17220347

  • 1. Variant in sex hormone-binding globulin gene and the risk of prostate cancer.
    Berndt SI, Chatterjee N, Huang WY, Chanock SJ, Welch R, Crawford ED, Hayes RB.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):165-8. PubMed ID: 17220347
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer.
    Cunningham JM, Hebbring SJ, McDonnell SK, Cicek MS, Christensen GB, Wang L, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN.
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):969-78. PubMed ID: 17507624
    [Abstract] [Full Text] [Related]

  • 3. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 4. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Hsing AW, Crawford ED, Andriole GL, Kaaks R, Hayes RB.
    Int J Cancer; 2008 May 15; 122(10):2345-50. PubMed ID: 18172860
    [Abstract] [Full Text] [Related]

  • 5. Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men.
    Shiota M, Fujimoto N, Tsukahara S, Ushijima M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Eto M.
    Clin Genitourin Cancer; 2019 Jun 15; 17(3):e387-e393. PubMed ID: 31036465
    [Abstract] [Full Text] [Related]

  • 6. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK.
    Cancer Epidemiol Biomarkers Prev; 2001 Oct 15; 10(10):1077-82. PubMed ID: 11588134
    [Abstract] [Full Text] [Related]

  • 7. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
    Kataoka N, Cai Q, Xu WH, Xiang YB, Cai H, Zheng W, Shu XO.
    Cancer; 2007 Apr 01; 109(7):1296-302. PubMed ID: 17315164
    [Abstract] [Full Text] [Related]

  • 8. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y, Shu XO, Cai Q, Jin F, Cheng JR, Cai H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1096-101. PubMed ID: 15894658
    [Abstract] [Full Text] [Related]

  • 9. Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.
    Garcia-Closas M, Brinton LA, Lissowska J, Richesson D, Sherman ME, Szeszenia-Dabrowska N, Peplonska B, Welch R, Yeager M, Zatonski W, Chanock SJ.
    BMC Cancer; 2007 Apr 05; 7():60. PubMed ID: 17411440
    [Abstract] [Full Text] [Related]

  • 10. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
    Price DK, Chau CH, Till C, Goodman PJ, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Parnes HL, Schenk JM, Tangen CM, Thompson IM, Reichardt JK, Figg WD.
    Cancer; 2016 Aug 01; 122(15):2332-40. PubMed ID: 27164191
    [Abstract] [Full Text] [Related]

  • 11. Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men.
    Huhtaniemi IT, Pye SR, Holliday KL, Thomson W, O'Neill TW, Platt H, Payne D, John SL, Jiang M, Bartfai G, Boonen S, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Labrie F, Wu FC, European Male Aging Study Group.
    J Clin Endocrinol Metab; 2010 Apr 01; 95(4):1898-908. PubMed ID: 20173016
    [Abstract] [Full Text] [Related]

  • 12. Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.
    Abrahamson PE, Tworoger SS, Aiello EJ, Bernstein L, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R, Baumgartner K, Sorensen B, Ballard-Barbash R, McTiernan A.
    Breast Cancer Res Treat; 2007 Sep 01; 105(1):45-54. PubMed ID: 17077994
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
    Dušenka R, Tomaškin R, Kliment J, Dobrota D, Dušenková S, Vilčková M, Sivoňová MK.
    Mol Med Rep; 2014 Dec 01; 10(6):3151-6. PubMed ID: 25310105
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women.
    Martínez-García MÁ, Gambineri A, Alpañés M, Sanchón R, Pasquali R, Escobar-Morreale HF.
    Hum Reprod; 2012 Dec 01; 27(12):3569-76. PubMed ID: 23001781
    [Abstract] [Full Text] [Related]

  • 17. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
    Salam MT, Ursin G, Skinner EC, Dessissa T, Reichardt JK.
    Urol Oncol; 2005 Dec 01; 23(4):246-53. PubMed ID: 16018939
    [Abstract] [Full Text] [Related]

  • 18. Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women.
    Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, Folkerd E, Luben RN, Cox D, Ballinger D, Pharoah PD, Ponder BA, Dunning AM, Easton DF, Studies in Epidemiology and Risks of Cancer Heredity Team.
    Cancer Epidemiol Biomarkers Prev; 2008 Dec 01; 17(12):3490-8. PubMed ID: 19064566
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C, Witte T, Robles P, Llumipanta W, Díaz M, Arévalo M.
    Cancer Genet Cytogenet; 2009 Mar 01; 189(2):71-6. PubMed ID: 19215786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.